
Immune resilience at the cellular level.
Thymosin-driven immune fortification for daily defense.
LifeShield is a Thymosin Alpha-1 protocol developed to strengthen adaptive immunity and modulate inflammatory response.
Thymosin Alpha-1 upregulates dendritic cell signaling and rebalances Th1/Th2 immune pathways for sharper, more resilient defense.
1.5 mg subcutaneous, 2× weekly for 8–12 weeks.
Reconstitute and inject subcutaneously into the abdomen. Rotate injection sites between doses.
Refrigerate reconstituted vials at 2–8 °C. Use within 30 days of reconstitution.
Most users report measurable changes within 2–4 weeks of consistent use. Full results typically emerge across an 8–12 week protocol.
Yes. Our compounds are designed to be modular. Pair with complementary stacks from Recovery, Longevity, or Metabolic collections — our specialists can recommend a structure.
Every batch ships with a Certificate of Analysis verifying purity above 99% from an independent ISO-accredited lab.
Unopened, temperature-intact vials may be returned within 14 days. Opened compounds are non-returnable for safety reasons.